It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Optochemistry, an emerging pharmacologic approach in which light is used to selectively activate or deactivate molecules, has the potential to alleviate symptoms, cure diseases, and improve quality of life while preventing uncontrolled drug effects. The development of in-vivo applications for optochemistry to render brain cells photoresponsive without relying on genetic engineering has been progressing slowly. The nucleus accumbens (NAc) is a region for the regulation of slow-wave sleep (SWS) through the integration of motivational stimuli. Adenosine emerges as a promising candidate molecule for activating indirect pathway neurons of the NAc expressing adenosine A2A receptors (A2ARs) to induce SWS. Here, we developed a brain-permeable positive allosteric modulator of A2ARs (A2AR PAM) that can be rapidly photoactivated with visible light (λ > 400 nm) and used it optoallosterically to induce SWS in the NAc of freely behaving male mice by increasing the activity of extracellular adenosine derived from astrocytic and neuronal activity.
The nucleus accumbens integrates sleep and motivation in mice. Here, the authors show sleep induction by increasing the activity of extracellular adenosine from astrocytes and neurons at A2A receptors with a photoactivatable allosteric modulator.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


















1 University of Tsukuba, International Institute for Integrative Sleep Medicine (WPI-IIIS), Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728)
2 University of Tsukuba, International Institute for Integrative Sleep Medicine (WPI-IIIS), Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); Wenzhou Medical University, Oujiang Laboratory (Zhejiang Laboratory for Regenerative Medicine, Vision and Brain Health), School of Ophthalmology & Optometry and Eye Hospital, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990)
3 Fudan University, Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Medical Neurobiology, Institutes of Brain Science and Collaborative Innovation Center for Brain Science, Joint International Research Laboratory of Sleep, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Wannan Medical College, School of Pharmacy, Wuhu, China (GRID:grid.443626.1) (ISNI:0000 0004 1798 4069)
4 University of Tsukuba, International Institute for Integrative Sleep Medicine (WPI-IIIS), Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); University of Tsukuba, PhD Program in Humanics, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728)
5 Chinese Academy of Sciences, State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309)
6 Hiroshima University, Department of Chemistry, Graduate School of Advanced Science and Engineering, Hiroshima University Research Center for Photo-Drug-Delivery Systems (HiU-P-DDS), Higashi-Hiroshima, Japan (GRID:grid.257022.0) (ISNI:0000 0000 8711 3200)
7 Veterans Administration Boston Healthcare System and Harvard Medical School, Department of Psychiatry, West Roxbury, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
8 Peking University, New Cornerstone Science Laboratory, State Key Laboratory of Membrane Biology, School of Life Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
9 Fudan University, Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Medical Neurobiology, Institutes of Brain Science and Collaborative Innovation Center for Brain Science, Joint International Research Laboratory of Sleep, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
10 University of Tsukuba, International Institute for Integrative Sleep Medicine (WPI-IIIS), Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); University of Tsukuba, Institute of Medicine, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728)